Riparin IV

synthetic alkamide drug analog to Aniba riparia natural compounds formed from condensation between acyl chlorides and O-methyltyramine

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Gutierrez, Stanley Juan Chavez: 2 articles (01/2020 - 12/2016)
2.	Barbosa Filho, José Maria: 1 article (01/2020)
3.	Barbosa, Giovanna Riello: 1 article (01/2020)
4.	Capibaribe, Victor Celso Cavalcanti: 1 article (01/2020)
5.	Chaves, Raquell de Castro: 1 article (01/2020)
6.	Fonteles, Marta Maria de França: 1 article (01/2020)
7.	Lopes, Iardja Stéfane: 1 article (01/2020)
8.	Mallmann, Auriana Serra Vasconcelos: 1 article (01/2020)
9.	Valentim, José Tiago: 1 article (01/2020)
10.	da Silva, Daniel Moreira Alves: 1 article (01/2020)

1.	Cognitive Dysfunction 01/01/2020 - "Based on these findings, this study aimed to investigate the possible effects of Riparin IV (Rip IV) on cognitive impairment induced by chronic administration of corticosterone in mice. " 01/01/2020 - "The neuroprotective effect of Riparin IV on oxidative stress and neuroinflammation related to chronic stress-induced cognitive impairment."
2.	Pain (Aches) 12/21/2016 - "Pharmacological Properties of Riparin IV in Models of Pain and Inflammation."
3.	Inflammation (Inflammations) 12/21/2016 - "Pharmacological Properties of Riparin IV in Models of Pain and Inflammation." 12/21/2016 - "In fact, riparin IV (1.56-25 mg/kg) produced dose-related antinociceptive and antiedematogenic effects on the complete Freund's adjuvant (CFA)-induced paw inflammation in mice. " 12/21/2016 - "During CFA-induced inflammation, riparin IV did not modulate either the production of cytokines, TNF-α and IL-10, or COX-2 mRNA expression. "
4.	Neuroinflammatory Diseases 01/01/2020 - "The neuroprotective effect of Riparin IV on oxidative stress and neuroinflammation related to chronic stress-induced cognitive impairment."